Kevin Fitzgerald

Chief Tech/Sci/R&D Officer at ALNYLAM PHARMACEUTICALS, INC.

Net worth: 6 M $ as of 2026-05-30

58 year

Health Technology

Consumer Services

Profile

Currently, Kevin Fitzgerald occupies the position of Chief Scientific Officer & Senior Vice President at Alnylam Pharmaceuticals, Inc. He received an undergraduate degree from Cornell University and a doctorate from Princeton University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ALNYLAM PHARMACEUTICALS, INC 0.02%	2026-03-04	21,106 ( 0.02% )	6 M $	2026-05-30
OVID THERAPEUTICS INC. 0.01%	2026-04-16	17,578 ( 0.01% )	47 988 $	2026-05-30

Kevin Fitzgerald active positions

Companies	Position	Start
ALNYLAM PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	2016-08-31
OVID THERAPEUTICS INC.	Director/Board Member	2021-10-05

All active positions of Kevin Fitzgerald

Training of Kevin Fitzgerald

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kevin Fitzgerald's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Ovid Therapeutics, Inc. Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders	Health Technology
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference	Health Technology
Cornell University Cornell University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Princeton University Princeton University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services